Clinical trial · Observational
Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma
NCT06146127CI-TRIAL-00071684PREMED-CHCunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Our project is a large-scale characterisation of cHCC-CCA will allow us to determine which subsets harbor actionable gene alterations. We will also aim to improve diagnosis of this tumor type by the use of immunohistochemical biomarkers and the development of deep-learning based models able to help cHCC-CCA diagnosis. This will represent an important step towards precision medicine for the patients with this highly aggressive malignancy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cancer | Malignant Liver Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| phenotyping | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Combined hepatocellular cholangiocarcinoma
- interventionNames
- Other: phenotyping
- label
- hepatocellular carcinoma
- interventionNames
- Other: phenotyping
- label
- cholangiocarcinoma
- interventionNames
- Other: phenotyping
Primary outcomes (1)
- measure
- Diagnosos
- timeFrame
- 3 yrs
- description
- Tumor subgroups
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: histological diagnosis of combined tumor biological sample available Exclusion Criteria: unequivocal histological features
References
Publications (0)
Data not yet available
No reference posted for this study.